Biocon Ceo Kiran Majumdar Shaw
- All
- News
- Videos
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Biocon's Generic Calcium Tablet Gets European Approval
Biotech major Biocon has received its first generic formulation approval in Europe, paving way for the company to launch Rosuvastatin Calcium tablets in several European countries.
-
Budget Battleground: A tale of two Indias
India is a developing country but a huge economic divide poses a major challenge to its growth. The gap between the haves and the have nots is widening continously but solution to the problem can't be seen in the near future.
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Biocon's Generic Calcium Tablet Gets European Approval
Biotech major Biocon has received its first generic formulation approval in Europe, paving way for the company to launch Rosuvastatin Calcium tablets in several European countries.
-
Budget Battleground: A tale of two Indias
India is a developing country but a huge economic divide poses a major challenge to its growth. The gap between the haves and the have nots is widening continously but solution to the problem can't be seen in the near future.
